from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2086/-

LFCtreatmentdescriptionclass of inhibitor

-0.055

Amikacinug/mL Amikacintranslation

-0.327

Cap5-10ug/mL Capreomycintranslation

1.255

Rox10-50 ug/mL Roxithromycintranslation

-0.610

SM2-5 ug/mL Streptomycintranslation

-2.827

Tet5-10 ug/mL Tetracyclinetranslation

0.608

Rif0.2-5ug/mL Rifampicintranscription

0.137

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.498

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.824

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.168

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.416

Clofazimine10-13 ug/mL Clofaziminerespiration

-1.122

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.181

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.006

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.870

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

1.192

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

1.709

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.908

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

1.099

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.310

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

1.070

Nigericin50 uM Nigericinrespiration

-0.054

TRC10-150 ug/mL Triclosanrespiration

0.518

TRZ10-25 ug/mL Thioridazinerespiration

0.662

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.634

menadione6-10 ug/mL Menadionerespiration

0.313

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.003

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.541

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-1.210

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.329

NRP_1Non-replicating persistence stage 1dosRassociated

-0.109

Amp0.2mg/mL AmpicillincellWall

0.173

Cephalexin20-100 ug/mL CephalexincellWall

0.023

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.415

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.311

EMB10-20 ug/mL EthambutolcellWall

-0.874

Eta12-40 ug/mL EthionamidecellWall

-0.493

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.546

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.755

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.109

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.220

BZA0.12 mg/mL BenzamidearomaticAmides

0.505

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.305

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.334

H2O24 mM hydrogen peroxideDNAdamaging

0.349

Levo10 ug/mL LevofloxacinDNAdamaging

0.016

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.029

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.045

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.074

UVUV-irradiationDNAdamaging

0.347

ARP41-4 ug/mL Antitubercular compound ARP4?

0.238

Antimycin12.5-50 ug/mL Antimycin A?

0.217

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.218

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.506

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.635

PA8240.2-2 ug/mL PA-824?

-0.869

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.474

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.337

Verapamil50 uM Verapamil?

0.751

mercaptoethanol2 mM 2-Mercaptoethanol?

0.529

methoxatin10-20 ug/mL Methoxatin?